ARCA BIOPHARMA ANNOUNCES FISCAL YEAR 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Posted on February 27, 2019 by ARCA IT - Press Release, Uncategorized ABIO - YE18 Financial Results and Business Update - FINAL
ARCA BIOPHARMA ANNOUNCES FDA AGREEMENT FOR A SINGLE PHASE 3 CLINICAL TRIAL TO SUPPORT APPROVAL FOR THE FIRST GENETICALLY-TARGETED CARDIOVASCULAR DRUG Posted on February 20, 2019 by ARCA IT - Press Release, Uncategorized Gencaro Phase 3 FDA SPA Agreement - FINAL